Page last updated: 2024-11-05

thiethylperazine and Dementia

thiethylperazine has been researched along with Dementia in 1 studies

Thiethylperazine: A dopamine antagonist that is particularly useful in treating the nausea and vomiting associated with anesthesia, mildly emetic cancer chemotherapy agents, radiation therapy, and toxins. This piperazine phenothiazine does not prevent vertigo or motion sickness. (From AMA Drug Evaluations Annual, 1994, p457)
thiethylperazine : A member of the class of phenothiazines that is perazine substituted by a ethylsulfanyl group at position 2.

Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ekstrand, T1
Ekbom, K1

Other Studies

1 other study available for thiethylperazine and Dementia

ArticleYear
[Chronic hyperkinesis caused by Torecan administration].
    Nordisk medicin, 1971, Nov-11, Volume: 86, Issue:45

    Topics: Aged; Dementia; Humans; Hyperkinesis; Middle Aged; Thiethylperazine

1971